A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision

Haemophilia

Volumn 12, Issue 2, 2006, Pages 187-189

  Leblebisatan, Göksel ^a   Sasmaz, I ^a   Antmen, B ^a   Kilinc, Y ^a   Sizmaz, S ^a   Yagmur, M ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Cataract; Factor VIIa; Haemophilia; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING TIME; CASE REPORT; CATARACT; CATARACT EXTRACTION; CIRCUMCISION; DRUG DOSE REGIMEN; DRUG MEGADOSE; ECCHYMOSIS; HEMOPHILIA A; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PRIORITY JOURNAL; SCROTUM DISORDER; THROMBOCYTE COUNT; VISUAL ACUITY;

ADOLESCENT; BLOOD COAGULATION FACTOR INHIBITORS; CATARACT EXTRACTION; CIRCUMCISION, MALE; COAGULANTS; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HEMOSTASIS, SURGICAL; HUMANS; ISOANTIBODIES; MALE; RECOMBINANT PROTEINS;

EID: 33645977172     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01191.x     Document Type: Article

References (11)

1. Hvid I, Rodriguez-Merchan EC. Orthopaedic surgery in haemophilic patients with inhibitors: An overview. Haemophilia 2002; 8: 288-91.
2. Saba HI, Morelli GA, Azam RR, Klein CJ, Letson GD. Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitors. Haemophilia 2003; 9: 131-6.
3. Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in haemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost 2000; 26: 425-32.
4. O'Connell N, McMahon C, Smith J et al. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors. Br J Haematol 2002; 116: 632-5.
5. Leibovitch L, Kenet G, Mazor K et al. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery. Pediatr Crit Care Med 2003; 4: 444-6.
6. Caglar K, Cetinkaya A, Aytac S, Gumruk F, Gurgey A. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatr Hematol Oncol 2003; 20: 435-8.
7. Poon MC. Management of thrombocytopenic bleeding: Is there a role for recombinant coagulation factor VIIa? Curr Hematol Rep 2003; 2: 139-47.
8. Laurian Y. Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa ? Pathophysiol Haemost Thromb 2002; 32 (Suppl. 1): 37-40.
9. Smith OP. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors. Pathophysiol Haemost Thromb 2002; 32 (Suppl. 1): 22-25.
10. White WL, Mundis RJ. Delayed orbital hemorrhage after cataract surgery in a patient with an acquired factor VIII inhibitor, MD. Am J Ophthalmol 2001; 132: 785-6.
11. Biron-Andreani C, Dupeyron G, Mainemer M, Schved JF. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery. Blood Coagul Fibrinolysis 2001; 12: 215-6.